Clinical and Biological Psychology, University of Ulm
Ulm, Germany
NCT Number: NCT02667314
Meta-analyses indicate beneficial effects of cognitive training and cognitively challenging video games on cognition. However, cognitive effects of solving jigsaw puzzles - a popular, visuospatial cognitive leisure activity - have not been investigated, yet. Thus, the primary aim of this study is to evaluate the effect of solving jigsaw puzzles on visuospatial cognition. As secondary aims, effects on psychological outcomes (self-efficacy, perceived stress, well-being) and visuospatial everyday functioning (instrumental activities of daily living and self-reported cognitive failures in everyday life) are examined.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Ulm, Germany
see References section below for the study protocol article
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention period 1: Participants are asked to solve jigsaw puzzles at home 6 times per week for at least 1 hour over a period of 5 weeks.
Intervention period 2 (voluntary): Participants receive the possibility to solve jigsaw puzzles free-of-charge at home for a period of at least 3 month before the 1.5-year follow-up.
Cognitive health counseling regarding modifiable risk and protective factors of cognitive decline and dementia at baseline, and four telephone calls for expert monitoring (three calls during the 5-week period between pre- and posttest, and one call 12 month later)
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Averaged score of eight z-standardized visuospatial cognitive ability scores (see secondary outcomes 2 - 9)
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Judgment of Line Orientation Test
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Copying in Complex Figure Tests; parallel versions for baseline and post-test
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Mental Rotations Test-Letters (2D) and Form A (3D)
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Trail Making Test A
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Trail Making Test B
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Block span (Wechsler Memory Scale, German version)
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Block design (Wechsler Adult Intelligence Scale-III, German version)
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Recall in Complex Figure Tests (sum score of immediate and delayed recall); parallel versions for baseline and post-test
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Averaged score of three z-standardized psychological health sub-scores (see secondary outcomes 11 - 13)
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
WHO-Five Well-being Index (WHO-5), German version
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
General Self-Efficacy Scale, German version
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
Perceived Stress Scale-14, German translation
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
TIADL (1-3): Timed instrumental activities of daily living (Task 1-3; sum-score)
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
CFQ (visuospatial items): Cognitive Failures Questionnaire, sum score of visuo-spatial items; German version
Time frame: Baseline and post intervention (after 5 weeks and 1.5 years)
40-pieces mini puzzle (completed pieces per minute)
Time frame: 1.5-year follow-up
Hair cortisol will be measured in 1cm segements
Time frame: 1.5-year follow-up
Hair dehydroepiandrosteron will be measured in 1cm segements
Time frame: 1.5-year follow-up
Hair brain-derived neurotrophic factor will be measured in 1cm segements
Time frame: 1.5-year follow-up
Neurocognitive disorder is a categorical outcome and includes mild and major neurocognitive disorders. Mild neurocognitive disorder (mild cognitive impairment) is defined by subjective cognitive decline (self-report), and an objective cognitive impairments in at least one cognitive abilitiy score (below -1 SD of the norm group), without an essential impairment of daily functioning compared to the premorbid level (self-report). In major neurocognitive decline (dementia), in addition to cognitive decline and impairment, daily functioning is essentially impaired compared to the permorbid level (self-report).
University of Ulm
Other
Jigsaw Puzzles As Cognitive Enrichment
Acronym: PACE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07041008
Alzheimer Disease, Anxiety Disorders
Leiria, Leria, Portugal
View Trial DetailsNCT03682185
Aberrant Motor Behavior in Dementia, Alzheimer Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03816644
Brain Diseases, Central Nervous System Diseases
The Bronx, New York, United States
View Trial DetailsNCT05433493
Alzheimer Disease, Brain Diseases
Mealhada, Aveiro District, Portugal
View Trial Details